The Hyperechoic Appearance of the Deltoid Muscle on Shoulder Ultrasound Imaging as a Predictor of Diabetes and Prediabetes.
deltoid
diabetes
glycogen
musculoskeletal ultrasound
prediabetes
shoulder
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
14
04
2019
revised:
27
06
2019
accepted:
07
07
2019
pubmed:
20
8
2019
medline:
18
11
2020
entrez:
20
8
2019
Statut:
ppublish
Résumé
To evaluate whether the ultrasound appearance of the deltoid muscle in diabetic patients differs from that in obese nondiabetic patients. Ultrasound images of the deltoid muscle from 137 type 2 diabetic patients (including 13 prediabetic patients) and 49 obese nondiabetic patients were blindly reviewed by 2 musculoskeletal radiologists, and by a third when arbitration was needed, to determine whether the appearance was "normal," "suspected diabetes," or "definite diabetes." Age, sex, race, body mass index (BMI), insulin use, and hemoglobin A The type 2 diabetic patients included 98 women and 39 men aged 29 to 92 years, and the nondiabetic patients included 19 women and 30 men aged 18 to 75 years. A consensus diagnosis of definite diabetes by the musculoskeletal radiologists based on a hyperechoic deltoid was a powerful predictor of diabetes, with a positive predictive value of 89%. A hyperechoic deltoid was also a powerful predictor of prediabetes. Of the 13 prediabetic patients, all had the same hyperechoic appearance of the diabetic deltoid, regardless of BMI. Although obese diabetic patients more often had a diagnosis of definite diabetes, the BMI alone could not explain the increased echogenicity, as obese nondiabetic patients' deltoid muscles did not appear as hyperechoic and were correctly categorized as not having definite diabetes with 82% specificity. The characteristic hyperechoic deltoid appearance is a strong predictor of both diabetes and prediabetes and differs from that of obese nondiabetic patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-329Informations de copyright
© 2019 by the American Institute of Ultrasound in Medicine.
Références
Lee MH, Sheehan SE, Orwin JF, Lee KS. Comprehensive shoulder US examination: a standardized approach with multimodality correlation for common shoulder disease. Radiographics 2016; 36:1606-1627.
Alves TI, Girish G, Kalume Brigido M, Jacobson JA. US of the knee: scanning techniques, pitfalls, and pathologic conditions. Radiographics 2016; 36:1759-1775.
Soliman SB, Spicer PJ, van Holsbeeck MT. Sonographic and radiographic findings of posterior tibial tendon dysfunction: a practical step forward. Skeletal Radiol 2019; 48:11-27.
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention; 2017.
Park M, Park JS, Ahn SE, Ryu KN, Park SY, Jin W. Sonographic findings of common musculoskeletal diseases in patients with diabetes mellitus. Korean J Radiol 2016; 17:245-254.
Baker JC, Demertzis JL, Rhodes NG, Wessell DE, Rubin DA. Diabetic musculoskeletal complications and their imaging mimics. Radiographics 2012; 32:1959-1974.
Merashli M, Chowdhury TA, Jawad AS. Musculoskeletal manifestations of diabetes mellitus. QJM 2015; 108:853-857.
Riazi S, Bril V, Perkins BA, et al. Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study. Diabetes Care 2012; 35:2575-2579.
Schafer AL, Vittinghoff E, Lang TF, et al. Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. J Clin Endocrinol Metab 2010; 95:E368-E372.
National Institutes of Health. Accelerating Medicines Partnership (AMP): type 2 diabetes. National Institutes of Health website. https://www.nih.gov/research-training/accelerating-medicines-partnership-amp/type-2-diabetes. Accessed August 21, 2018.
van Holsbeeck MT, Introcaso JH (eds). Musculoskeletal Ultrasound. 3rd ed. Philadelphia, PA: Jaypee Brothers Medical Publishers; 2016.
Garcilazo C, Cavallasca JA, Musuruana JL. Shoulder manifestations of diabetes mellitus. Curr Diabetes Rev 2010; 6:334-340.
Hsu CL, Sheu WH. Diabetes and shoulder disorders. J Diabetes Investig 2016; 7:649-651.
Abate M, Schiavone C, Salini V. Sonographic evaluation of the shoulder in asymptomatic elderly subjects with diabetes. BMC Musculoskelet Disord 2010; 11:278.
Jacobson JA. Shoulder ultrasound. In: Jacobson JA (ed). Fundamentals of Musculoskeletal Ultrasound. 3rd ed. Philadelphia, PA: Elsevier; 2018;55-126.
Pillen S. Skeletal muscle ultrasound. Eur J Transl Myol 2010; 20:145-156.
Khoury V, Cardinal E, Brassard P. Atrophy and fatty infiltration of the supraspinatus muscle: sonography versus MRI. AJR Am J Roentgenol 2008; 190:1105-1111.
Dow DF, Mehta K, Xu Y, England E. The relationship between body mass index and fatty infiltration in the shoulder musculature. J Comput Assist Tomogr 2018; 42:323-329.
Miljkovic-Gacic I, Wang X, Kammerer CM, et al. Fat infiltration in muscle: new evidence for familial clustering and associations with diabetes. Obesity (Silver Spring) 2008; 16:1854-1860.
Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther 2008; 88:1336-1344.
Miljkovic-Gacic I, Gordon CL, Goodpaster BH, et al. Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry. Am J Clin Nutr 2008; 87:1590-1595.
Reimers K, Reimers CD, Wagner S, Paetzke I, Pongratz DE. Skeletal muscle sonography: a correlative study of echogenicity and morphology. J Ultrasound Med 1993; 12:73-77.
Nieman DC, Shanely RA, Zwetsloot KA, Meaney MP, Farris GE. Ultrasonic assessment of exercise-induced change in skeletal muscle glycogen content. BMC Sports Sci Med Rehabil 2015; 7:9.
Greene J, Louis J, Korostynska O, Mason A. State-of-the-art methods for skeletal muscle glycogen analysis in athletes: the need for novel non-invasive techniques. Biosensors (Basel) 2017; 7:E11.
Hill JC, Millán IS. Validation of musculoskeletal ultrasound to assess and quantify muscle glycogen content: a novel approach. Phys Sportsmed 2014; 42:45-52.
Millán IS, Hill J, Wischmeyer P. Measurement of skeletal muscle glycogen status in critically ill patients: a new approach in critical care monitoring. Crit Care 2015; 19(suppl 1):P400.
Verbeek RJ, Sentner CP, Smit GP, et al. Muscle ultrasound in patients with glycogen storage disease types I and III. Ultrasound Med Biol 2016; 42:133-142.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(suppl 1):S62-S69.
Koenig RJ, Peterson CM, Kilo C, Cerami A, Williamson JR. Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes. Diabetes 1976; 25:230-232.
National Heart, Lung, and Blood Institute. Classification of overweight and obesity by BMI, waist circumference, and associated disease risks. National Heart, Lung, and Blood Institute website. https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmi_dis.htm. Accessed August 21, 2018.
Nishimura M, Nishimura S, Yamada S. Ultrasound imaging of the muscle in muscular dystrophy [in Japanese]. No To Hattatsu 1989; 21:234-238.
Groop L, Orho-Melander M. New insights into impaired muscle glycogen synthesis. PLoS Med 2008; 5:e25.
Jensen J, Rustad PI, Kolnes AJ, Lai YC. The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise. Front Physiol 2011; 2:112.
Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322:223-228.
He J, Kelley DE. Muscle glycogen content in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2004; 287:E1002-E1007.